Savvy Updates, 11/25/24:  FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

In this week’s issue of The Savvy Diabetic:  FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU...
Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design

Savvy Updates, 11/11/24: Rotate Infusion Sites, Dawn Phenomenon, Hidden Disabilities Sunflower, Insulin Resistence, US Diabetes Rates Rise, Companion Cards/Diabetes By Design

Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024. Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the...
Savvy Updates, 11/4/24:  O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

In this week’s issue of The Savvy Diabetic:  Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta Bionics Launches iLet with Abbott...
Savvy Updates: 10/28/24:  Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

Savvy Updates: 10/28/24: Insulin for BG Drops, Luna Diabetes Pivotal Trial, Levicure’s Triple-Combo Therapy, T1D GLP-1/SGLT2 Use, DTS Innovations, Semaglutide/T1D/Alzheimer’s, Hospitalizations by Age, Insurance Companies’ Woes

In this week’s issue of The Savvy Diabetic:  New Insulin to Prevent Sudden BG Drops Luna Diabetes Clinical Trial for AID Closed-Loop for MDI Levicure’s Triple-Combo Oral Therapy to Restore Insulin Production GLP-1, SGLT2 Drug Scripts on the Rise...
Skip to content